MedDataX Logo

The Role of Cervical Consistency Index and Uterocervical Angles in Medical Termination

NCT ID: NCT06164067

Last Updated: 2023-12-11

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

136 participants

Study Classification

OBSERVATIONAL

Study Start Date

2022-02-15

Study Completion Date

2022-08-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The main aim of the investigator study is the success of predictivity cervical consistency index (CCI), anterior uterocervical angle (aUCA) and posterior uterocervical angle (pUCA) in second trimester terminations.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This prospective clinical study includes 136 pregnant women with a diagnosis of in utero ex fetus who were hospitalized for medical termination in the gynecology service of Health Sciences University Bursa High Specialization Training and Research Hospital Gynecology and Obstetrics Clinic as a single center. The participants were divided into 2 groups as those whose treatment was completed in the first 24 hours (who were completely aborted and removed the fetal material and its attachments ) and those who aborted within 24-48 hours when additional cycles were needed. Furthermore who applied to additional treatment methods were recorded (cervical balloon, hysterotomy ) during these periods. In all pregnant women; characteristic features, abortion times, doses of misoprostol used, anterior- posterior uterocervical angle, cervical length, cervical consistency indexes and gestational weeks were saved.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Second Trimester Abortion Uterocervical Angle Cervical Consistency Index

Keywords

Explore important study keywords that can help with search, categorization, and topic discovery.

medical termination uterocervical angle abortion second trimester

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Pregnant women who abort within 24 hours

Group 1 treatment was completed in the first 24 hours ( who were completely aborted and removed the fetal material and its attachments )

abortus within 24 hours or 24-48 hours

Intervention Type OTHER

second trimester medical termination

Pregnant women who abort within 24- 48 hours

Group 2 consisted of patients who needed additional cycles and aborted within 24-48 hours.

abortus within 24 hours or 24-48 hours

Intervention Type OTHER

second trimester medical termination

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

abortus within 24 hours or 24-48 hours

second trimester medical termination

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

misoprostol

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* women who had a termination indication in the second trimester and had abortion or abortion in our hospital
* women who have had a miscarriage or abortion with a normal vaginal route or hysterotomy

Exclusion Criteria

* multiple pregnancies
* pregnant women with misoprostol-related allergies
* scar pregnancies or heterotopic pregnancies
* patients with a history of previous conization or cervical surgery,
* patients with placental invasion anomaly
Minimum Eligible Age

18 Years

Maximum Eligible Age

45 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Sanliurfa Mehmet Akif Inan Education and Research Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Nefise Nazlı YENIGUL

Ph.D. Assistant Professor Department of Obstetrics and Gynecology

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Nefise Nazlı YENIGUL

Bursa, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2011-KAEK-25 2022/04-52

Identifier Type: -

Identifier Source: org_study_id